Huawei FusionServer Pro 2488H V6 Server Passes SAP HANA Appliance Certification 

SHENZHEN, China, Sept. 7, 2020 /PRNewswire/ -- Recently, Huawei's latest FusionServer Pro 2488H V6 server has passed the SAP ICC certification test and obtained the SAP HANA Appliance Certification. It is listed in the latest SAP integrated product certification list. This certification...

SHENZHEN, China, Sept. 7, 2020 /PRNewswire/ — Recently, Huawei’s latest FusionServer Pro 2488H V6 server has passed the SAP ICC certification test and obtained the SAP HANA Appliance Certification. It is listed in the latest SAP integrated product certification list. 

This certification further enriches the enablement of the SAP ecosystem and provides new business opportunities for both customers and ecosystem partners. 

Since the establishment of a global technical cooperation partnership in 2012, Huawei and SAP have been committed to consolidating their strengths. SAP’s software capabilities and Huawei’s infrastructure capabilities jointly provide efficient and reliable solutions for the enterprise market and provide high-quality services for global customers’ digital transformation. The SAP Partner Adoption Center facilitates strategic cooperation between the two parties, driving the joint innovation process to produce one-stop services for customers and partners. 

The SAP HANA appliance certification result of Huawei FusionServer Pro 2488H V6 is available at the SAP official website: https://www.sap.com/dmc/exp/2014-09-02-hana-hardware/enEN/appliances.html?textsearch=2488H+V6#categories=certified&search=2488H%20V6&recordid=2352 

Photo – https://mma.prnewswire.com/media/1249700/Huawei_FusionServer_Pro_2488H_V6_SAP_HANA_appliance_certification_results.jpg 

 

Leggi anche...
I più recenti

Sindrome da chilomicronemia familiare: l’EMA approva il nuovo farmaco Redemplo

Giappone, cresce il ruolo dei CDMO nello sviluppo dei farmaci a base di peptidi

Accesso alle terapie oncologiche mirate in Italia: un potenziale ancora inespresso

Endometriosi: avviata la fase 2 del trial NOVA con vipoglanstat di Gesynta Pharma

Newsletter

Iscriviti ora per rimanere aggiornato su tutti i temi inerenti la salute.